TSE: 9987 - Suzuken Co., Ltd.

Yield per half year: -0.5704%
Dividend yield: +2.56%
Sector: Healthcare

Suzuken Co., Ltd.

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
8/10
12.83 110.96 -88.44% 21.85 -41.28%
P/S 0.156 74.98 -99.79%
P/BV 0.8939 70.27 -98.73%
P/FCF 4.74 85.21 -94.44%
Ev/Ebitda 3.69 17.04 -78.34%
Ev/S 0.0798 72.28 -99.89%
Ev/FCF 2.66 27.12 -90.19%
E/P 0.0855 -0.1872 -145.66%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
1/10
2.16 -77.58 -102.79% 1.77 +22.44%
ROE 7.01 -9.31 -175.29%
ROA 2.44 -9.76 -125.05%
ROIC 6.45 9.09 -29.08%
ROS 1.22 -144.19 -100.84%
ROCE 9.64 5.93 62.61%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
0.035 -1.04 -103.36% 0.0521 -32.93%
Nеt Debt/Ebitda -3.53 12.46 -128.29%
Debt/Ratio 0.0015 0.1401 -98.95%
Debt/Equity 0.0043 24.72 -99.98%
Debt/Net Income 0.0621 -1.96 -103.17%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
6.4/10
2.56 2.66 -3.84% 2.08 +22.83%
Number of years of dividend growth 2 1.28 55.79%
DSI 0.8571 0.7385 16.06%
Average dividend growth 12.44 -18.33 -167.88%
Average percentage for 5 years 2.08 1.91 9.19%
Average percentage for payments 37.82 33.95 11.4%
Difference from average difference in sector -0.1023

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
1/10
7.81 75.4 -89.64%
Growth impulse Ebitda in 5 years -1.27 61.75 -102.06%
Growth impulse Net Income in 5 years 2.86 34.02 -91.59%
Growth impulse FCF in 5 years -290.77 -19.39 1399.59%
Growth impulse EPS in 5 years 15.35 -67.91 -122.6%
IP Score
5.58/10

Similar companies

Takeda Pharmaceutical Company Limited

HOYA Corporation

Daiichi Sankyo Company, Limited

Chugai Pharmaceutical Co., Ltd.

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription